%0 Journal Article
%T Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
%A Alejandro Balsa
%A Alejandro Villalba
%A Ana Mart¨ªnez-Feito
%A Annick de Vries
%A Chamaida Plasencia-Rodr¨ªguez
%A Cristina Diego
%A Diana Peiteado
%A Dora Pascual-Salcedo
%A Eva-Mar¨ªa Olariaga
%A Karien Bloem
%A Laura Nu£¿o
%A Maria-Gema Bonilla
%A Teresa Jurado
%A Theo Rispens
%A Victoria Navarro-Comp¨¢n
%J Archive of "The Open Rheumatology Journal".
%D 2017
%R 10.2174/1874312901711010075
%X The Infliximab, has proven effective in treating rheumatoid arthritis (RA). A good clinical response is usually associated with high serum drug levels. Development of antibodies toward Infliximab (ATI) can increase drug clearance, leading to treatment failure
%K Infliximab therapy
%K Rheumatoid Arthritis
%K Induction phase
%K Levels clearance
%K Loss of efficacy
%K Early immunogenicity
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510569/